HCM
NVRO

Hollencrest Capital Management’s NEVRO CORP. NVRO Stock Holding History

Hollencrest Capital Management’s Portfolio NVRO Stock Details NVRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-500
Closed -$2.79K – 1234
2024
Q3 		$2.79K Hold
500
– – ﹤0.01% 917
2024
Q2 		$4.21K Hold
500
– – ﹤0.01% 858
2024
Q1 		$7.22K Buy
+500
New +$8.27K ﹤0.01% 752

Other funds holding NVRO

ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Hollencrest Capital Management's NVRO Position: Q4 2024 in Review

Hollencrest Capital Management sold out of NEVRO CORP. (NVRO) in Q4 2024, closing a stake of 500 shares — an estimated $2.79K sold.

Hollencrest Capital Management first reported a position in NVRO in Q1 2024 and held it in 3 quarters. The position peaked at $7.22K in Q1 2024. 129 funds tracked by Wall St. Rank hold NVRO as of Q4 2024.

  • Hollencrest Capital Management reported no remaining NEVRO CORP. position as of Q4 2024 after selling out during the quarter.
  • Hollencrest Capital Management sold 500 NEVRO CORP. shares in Q4 2024, an estimated $2.79K.
  • Hollencrest Capital Management first reported a position in NEVRO CORP. in Q1 2024 and held it in 3 quarters.
  • Hollencrest Capital Management's NEVRO CORP. position peaked at $7.22K in Q1 2024.
  • 129 funds tracked by Wall St. Rank held NEVRO CORP. as of Q4 2024.

Based on Hollencrest Capital Management's 13F filing for Q4 2024, filed 10 Feb 2025.